コロナ新薬候補、治験開始米メルクが開発中の「モルヌピラビル」Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19 - Merck.comU.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administrat…www.merck.comとスイスのロシュが手掛ける「ＡＴ―５２７」Home | Atea PharmaceuticalsAtea Pharmaceuticals is a leader in the discovery of oral direct-acting antiviral therapies, including our most advanced drug candidate, AT-527.ateapharma.comAtea’s AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitalized Patients with COVID-19 in Phase 2 Interim AnalysisPhase 2 Interim Virology Results Indicate Rapid and Sustained Antiviral Activity Against SARS-CoV-2 in Patients with COVID-19 in the Hospitalized Setting ...www.globenewswire.comぎゃーっ🤭これって、あれですよね？例のイベルメクチンコロナ新薬候補、治験開始新型コロナウイルス感染症治療に絡み、海外の製薬大手２社が口から飲む新薬候補の最終段階の臨床試験（治験）を日本で始めたことが５日、分かった。コロナの特効薬がない中、症状が出始めた段階で自宅でも服用して重症化を防ぐ経口薬として実用化を目指している。www.google.com日本で興和がやるって発表したばかりなのになぜアメリカやスイスの製薬会社が日本で治験をやるんだよ？そんなことなら、ワクチンの前にとっとと出しとけって感じ。で、これは治験でも反ワクチン派には歓迎されるんだね？こぞって承認前でも治験中の薬飲みたがるんだろう。やっぱり製薬会社の裏と闇は大きい...
Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19 - Merck.comU.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administrat…www.merck.com
Atea’s AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitalized Patients with COVID-19 in Phase 2 Interim AnalysisPhase 2 Interim Virology Results Indicate Rapid and Sustained Antiviral Activity Against SARS-CoV-2 in Patients with COVID-19 in the Hospitalized Setting ...www.globenewswire.com
コロナ新薬候補、治験開始新型コロナウイルス感染症治療に絡み、海外の製薬大手２社が口から飲む新薬候補の最終段階の臨床試験（治験）を日本で始めたことが５日、分かった。コロナの特効薬がない中、症状が出始めた段階で自宅でも服用して重症化を防ぐ経口薬として実用化を目指している。www.google.com
